Metabolic engineering最新文献

{"title":"Inferring secretory and metabolic pathway activity from omic data with secCellFie","authors":"Helen O. Masson ,&nbsp;Mojtaba Samoudi ,&nbsp;Caressa M. Robinson ,&nbsp;Chih-Chung Kuo ,&nbsp;Linus Weiss ,&nbsp;Km Shams Ud Doha ,&nbsp;Alex Campos ,&nbsp;Vijay Tejwani ,&nbsp;Hussain Dahodwala ,&nbsp;Patrice Menard ,&nbsp;Bjorn G. Voldborg ,&nbsp;Bradley Robasky ,&nbsp;Susan T. Sharfstein ,&nbsp;Nathan E. Lewis","doi":"10.1016/j.ymben.2023.12.006","DOIUrl":"10.1016/j.ymben.2023.12.006","url":null,"abstract":"<div><p>Understanding protein secretion has considerable importance in biotechnology and important implications in a broad range of normal and pathological conditions including development, immunology, and tissue function. While great progress has been made in studying individual proteins in the secretory pathway, measuring and quantifying mechanistic changes in the pathway's activity remains challenging due to the complexity of the biomolecular systems involved. Systems biology has begun to address this issue with the development of algorithmic tools for analyzing biological pathways; however most of these tools remain accessible only to experts in systems biology with extensive computational experience. Here, we expand upon the user-friendly CellFie tool which quantifies metabolic activity from omic data to include secretory pathway functions, allowing any scientist to infer properties of protein secretion from omic data. We demonstrate how the secretory expansion of CellFie (secCellFie) can help predict metabolic and secretory functions across diverse immune cells, hepatokine secretion in a cell model of NAFLD, and antibody production in Chinese Hamster Ovary cells.</p></div>","PeriodicalId":18483,"journal":{"name":"Metabolic engineering","volume":null,"pages":null},"PeriodicalIF":8.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1096717623001799/pdfft?md5=fe08091f516bdd1ac5ce48a3328eea21&pid=1-s2.0-S1096717623001799-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138887191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Enhanced poly-γ-glutamic acid synthesis in Corynebacterium glutamicum by reconstituting PgsBCA complex and fermentation optimization","authors":"Guoqiang Xu ,&nbsp;Jiyue Wang ,&nbsp;Jiancheng Shen ,&nbsp;Yaxin Zhu ,&nbsp;Wanjing Liu ,&nbsp;Yuhang Chen ,&nbsp;Jian Zha ,&nbsp;Xiaomei Zhang ,&nbsp;Xiaojuan Zhang ,&nbsp;Jinsong Shi ,&nbsp;Mattheos A.G. Koffas ,&nbsp;Zhenghong Xu","doi":"10.1016/j.ymben.2023.12.008","DOIUrl":"10.1016/j.ymben.2023.12.008","url":null,"abstract":"<div><p>Previously, a novel <em>Corynebacterium glutamicum</em> strain for the de novo biosynthesis of tailored poly-γ-glutamic acid (γ-PGA) has been constructed by our group. The strain was based on the γ-PGA synthetase complex, PgsBCA, which is the only polyprotein complex responsible for γ-PGA synthesis in <em>Bacillus</em> spp. In the present study, PgsBCA was reconstituted and overexpressed in <em>C. glutamicum</em> to further enhance γ-PGA synthesis. First, we confirmed that all the components (PgsB, PgsC, and PgsA) of γ-PGA synthetase derived from <em>B. licheniformis</em> are necessary for γ-PGA synthesis, and γ-PGA was detected only when PgsB, PgsC, and PgsA were expressed in combination in <em>C. glutamicum</em>. Next, the expression level of each <em>pgsB</em>, <em>pgsC</em>, and <em>pgsA</em> was tuned in order to explore the effect of expression of each of the γ-PGA synthetase subunits on γ-PGA production. Results showed that increasing the transcription levels of <em>pgsB</em> or <em>pgsC</em> and maintaining a medium-level transcription level of <em>pgsA</em> led to 35.44% and 76.53% increase in γ-PGA yield (γ-PGA yield-to-biomass), respectively. Notably, the expression level of <em>pgsC</em> had the greatest influence (accounting for 68.24%) on γ-PGA synthesis, followed by <em>pgsB</em>. Next, genes encoding for PgsC from four different sources (<em>Bacillus subtilis</em>, <em>Bacillus anthracis</em>, <em>Bacillus</em> methylotrophicus<em>, and Bacillus amyloliquefacien</em>s) were tested in order to identify the influence of PgsC-encoding orthologues on γ-PGA production, but results showed that in all cases the synthesis of γ-PGA was significantly inhibited. Similarly, we also explored the influence of gene orthologues encoding for PgsB on γ-PGA production, and found that the titer increased to 17.14 ± 0.62 g/L from 8.24 ± 0.10 g/L when PgsB derived from B. methylotrophicus replaced PgsB alone in PgsBCA from <em>B. licheniformis</em>. The resulting strain was chosen for further optimization, and we achieved a γ-PGA titer of 38.26 g/L in a 5 L fermentor by optimizing dissolved oxygen level. Subsequently, by supplementing glucose, γ-PGA titer increased to 50.2 g/L at 48 h. To the best of our knowledge, this study achieved the highest titer for de novo production of γ-PGA from glucose, without addition of L-glutamic acid, resulting in a novel strategy for enhancing γ-PGA production.</p></div>","PeriodicalId":18483,"journal":{"name":"Metabolic engineering","volume":null,"pages":null},"PeriodicalIF":8.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1096717623001817/pdfft?md5=2b16e0c55fd2e5054d639d7facb55cd7&pid=1-s2.0-S1096717623001817-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139059584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Creating new-to-nature carbon fixation: A guide","authors":"Helena Schulz-Mirbach ,&nbsp;Beau Dronsella ,&nbsp;Hai He ,&nbsp;Tobias J. Erb","doi":"10.1016/j.ymben.2023.12.012","DOIUrl":"10.1016/j.ymben.2023.12.012","url":null,"abstract":"<div><p>Synthetic biology aims at designing new biological functions from first principles. These new designs allow to expand the natural solution space and overcome the limitations of naturally evolved systems. One example is synthetic CO₂-fixation pathways that promise to provide more efficient ways for the capture and conversion of CO₂<span> than natural pathways, such as the Calvin Benson Bassham (CBB) cycle of photosynthesis. In this review, we provide a practical guideline for the design and realization of such new-to-nature CO</span>₂-fixation pathways. We introduce the concept of “synthetic CO₂<span>-fixation”, and give a general overview over the enzymology and topology of synthetic pathways, before we derive general principles for their design from their eight naturally evolved analogs. We provide a comprehensive summary of synthetic carbon-assimilation pathways and derive a step-by-step, practical guide from the theoretical design to their practical implementation, before ending with an outlook on new developments in the field.</span></p></div>","PeriodicalId":18483,"journal":{"name":"Metabolic engineering","volume":null,"pages":null},"PeriodicalIF":8.4,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139074510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Selective microbial production of lacto-N-fucopentaose I in Escherichia coli using engineered α-1,2-fucosyltransferases","authors":"Shun Endo ,&nbsp;Tomotoshi Sugita ,&nbsp;Sayaka Kamai ,&nbsp;Kazuki Nakamura ,&nbsp;Fuhito Yamazaki ,&nbsp;Sotaro Sampei ,&nbsp;Gustautas Snarskis ,&nbsp;Audronė Valančiūtė ,&nbsp;Masoud Kazemi ,&nbsp;Irmantas Rokaitis ,&nbsp;Kento Koketsu","doi":"10.1016/j.ymben.2023.12.009","DOIUrl":"10.1016/j.ymben.2023.12.009","url":null,"abstract":"<div><p>Lacto-<em>N</em><span>-fucopentaose I (LNFP I) is the second most abundant fucosylated human milk oligosaccharide<span> (HMO) in breast milk after 2′-fucosyllactose (2′-FL). Studies have reported that LNFP I exhibits antimicrobial activity against group B </span></span><em>Streptococcus</em> and antiviral effects against <span><em>Enterovirus</em></span> and <span><em>Norovirus</em></span>. Microbial production of HMOs by engineered <em>Escherichia coli</em> is an attractive, low-cost process, but few studies have investigated production of long-chain HMOs, including the pentasaccharide LNFP I. LNFP I is synthesized by α1,2-fucosyltransfer reaction to the <em>N</em>-acetylglucosamine moiety of the lacto-<em>N</em><span>-tetraose skeleton, which is catalyzed by α1,2-fucosyltransferase (α1,2-FucT). However, α1,2-FucTs competitively transfer fucose to lactose, resulting in formation of the byproduct 2′-FL. In this study, we constructed LNFP I-producing strains of </span><em>E. coli</em> with various α1,2-fucTs, and observed undesired 2′-FL accumulation during fed-batch fermentation, although, in test tube assays, some strains produced LNFP I without 2′-FL. We hypothesized that promiscuous substrate selectivity of α1,2-FucT was responsible for 2′-FL production. Therefore, to decrease the formation of byproduct 2′-FL, we designed 15 variants of FsFucT from <span><em>Francisella</em></span><span> sp. FSC1006 by rational and semi-rational design approaches. Five of these variants of FsFucT surpassed a twofold reduction in 2′-FL production compared with wild-type FsFucT while maintaining comparable levels of LNFP I production. These designs encompassed substitutions in either a loop region of the enzyme (residues 154–171), or in specific residues (Q7, H162, and L164) that influence substrate binding either directly or indirectly. In particular, the </span><em>E. coli</em> strain that expressed FsFucT_S3 variants, with a substituted loop region (residues 154–171) forming an α-helix structure, achieved an accumulation of 19.6 g/L of LNFP I and 0.04 g/L of 2′-FL, while the <em>E. coli</em> strain expressing the wild-type FsFucT accumulated 12.2 g/L of LNFP I and 5.85 g/L of 2′-FL during Fed-bach fermentation. Therefore, we have successfully demonstrated the selective and efficient production of the pentasaccharide LNFP I without the byproduct 2′-FL by combining protein engineering of α1,2-FucT designed through <em>in silico</em><span> structural modeling of an α1,2-FucT and docking simulation with various ligands, with metabolic engineering of the host cell.</span></p></div>","PeriodicalId":18483,"journal":{"name":"Metabolic engineering","volume":null,"pages":null},"PeriodicalIF":8.4,"publicationDate":"2023-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138887265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Production of species-specific anthocyanins through an inducible system in plant hairy roots","authors":"Jie Liu ,&nbsp;Yuanxiu Zhao ,&nbsp;Jingmeng Zhang ,&nbsp;Yu Kong ,&nbsp;Pan Liu ,&nbsp;Yumin Fang ,&nbsp;Mengying Cui ,&nbsp;Tianlin Pei ,&nbsp;Xin Zhong ,&nbsp;Ping Xu ,&nbsp;Wenqing Qiu ,&nbsp;Dongfeng Yang ,&nbsp;Cathie Martin ,&nbsp;Qing Zhao","doi":"10.1016/j.ymben.2023.12.005","DOIUrl":"10.1016/j.ymben.2023.12.005","url":null,"abstract":"<div><p>Anthocyanins are widely distributed pigments in flowering plants with red, purple or blue colours. Their properties in promoting heath make anthocyanins perfect natural colourants for food additives. However, anthocyanins with strong colour and stability at neutral pH, suitable as food colourants are relatively rare in nature. Acylation increases anthocyanin stability and confers bluer colour. In this study, we isolated two anthocyanin regulators SbMyb75 and SbDel from <em>S. baicalensis</em>, and showed that constitutive expression of the two TFs led to accumulation of anthocyanins at high levels in black carrot hairy roots. However, these hairy roots had severe growth problems. We then developed a β-estradiol inducible system using XVE and a Lex-35S promoter, to initiate expression of the anthocyanin regulators and induced this system in hairy roots of black carrot, tobacco and morning glory. Anthocyanins with various decorations were produced in these hairy roots without any accompanying side-effects on growth. We further produced highly acylated anthocyanins with blue colour in a 5 L liquid culture in a bioreactor of hairy roots from morning glory. We provide here a strategy to produce highly decorated anthocyanins without the need for additional engineering of any of the genes encoding decorating enzymes. This strategy could be transferred to other species, with considerable potential for natural colourant production for the food industries.</p></div>","PeriodicalId":18483,"journal":{"name":"Metabolic engineering","volume":null,"pages":null},"PeriodicalIF":8.4,"publicationDate":"2023-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1096717623001787/pdfft?md5=03751cec0875a63d9fdda172c4529597&pid=1-s2.0-S1096717623001787-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138658098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Tuning of CHO secretional machinery improve activity of secreted therapeutic sulfatase 150-fold","authors":"Niklas Berndt Thalén ,&nbsp;Mona Moradi Barzadd ,&nbsp;Magnus Lundqvist ,&nbsp;Johanna Rodhe ,&nbsp;Monica Andersson ,&nbsp;Gholamreza Bidkhori ,&nbsp;Dominik Possner ,&nbsp;Chao Su ,&nbsp;Joakim Nilsson ,&nbsp;Peter Eisenhut ,&nbsp;Magdalena Malm ,&nbsp;Alice Karlsson ,&nbsp;Jeanette Vestin ,&nbsp;Johan Forsberg ,&nbsp;Erik Nordling ,&nbsp;Adil Mardinoglu ,&nbsp;Anna-Luisa Volk ,&nbsp;Anna Sandegren ,&nbsp;Johan Rockberg","doi":"10.1016/j.ymben.2023.12.003","DOIUrl":"10.1016/j.ymben.2023.12.003","url":null,"abstract":"<div><p>Rare diseases are, despite their name, collectively common and millions of people are affected daily of conditions where treatment often is unavailable. Sulfatases are a large family of activating enzymes related to several of these diseases. Heritable genetic variations in sulfatases may lead to impaired activity and a reduced macromolecular breakdown within the lysosome, with several severe and lethal conditions as a consequence. While therapeutic options are scarce, treatment for some sulfatase deficiencies by recombinant enzyme replacement are available. The recombinant production of such sulfatases suffers greatly from both low product activity and yield, further limiting accessibility for patient groups. To mitigate the low product activity, we have investigated cellular properties through computational evaluation of cultures with varying media conditions and comparison of two CHO clones with different levels of one active sulfatase variant. Transcriptome analysis identified 18 genes in secretory pathways correlating with increased sulfatase production. Experimental validation by upregulation of a set of three key genes improved the specific enzymatic activity at varying degree up to 150-fold in another sulfatase variant, broadcasting general production benefits. We also identified a correlation between product mRNA levels and sulfatase activity that generated an increase in sulfatase activity when expressed with a weaker promoter. Furthermore, we suggest that our proposed workflow for resolving bottlenecks in cellular machineries, to be useful for improvements of cell factories for other biologics as well.</p></div>","PeriodicalId":18483,"journal":{"name":"Metabolic engineering","volume":null,"pages":null},"PeriodicalIF":8.4,"publicationDate":"2023-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1096717623001763/pdfft?md5=5a0ae2bfd352b7b4d9f49d481e7be367&pid=1-s2.0-S1096717623001763-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138561884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Systems metabolic engineering of the primary and secondary metabolism of Streptomyces albidoflavus enhances production of the reverse antibiotic nybomycin against multi-resistant Staphylococcus aureus","authors":"Julian Stegmüller ,&nbsp;Marta Rodríguez Estévez ,&nbsp;Wei Shu ,&nbsp;Lars Gläser ,&nbsp;Maksym Myronovskyi ,&nbsp;Christian Rückert-Reed ,&nbsp;Jörn Kalinowski ,&nbsp;Andriy Luzhetskyy ,&nbsp;Christoph Wittmann","doi":"10.1016/j.ymben.2023.12.004","DOIUrl":"10.1016/j.ymben.2023.12.004","url":null,"abstract":"<div><p>Nybomycin is an antibiotic compound with proven activity against multi-resistant <em>Staphylococcus aureus</em>, making it an interesting candidate for combating these globally threatening pathogens. For exploring its potential, sufficient amounts of nybomycin and its derivatives must be synthetized to fully study its effectiveness, safety profile, and clinical applications. As native isolates only accumulate low amounts of the compound, superior producers are needed. The heterologous cell factory <em>S. albidoflavus</em> 4N24, previously derived from the cluster-free chassis <em>S. albidoflavus</em> Del14, produced 860 μg L⁻¹ of nybomycin, mainly in the stationary phase. A first round of strain development modulated expression of genes involved in supply of nybomycin precursors under control of the common P_erm* promoter in 4N24, but without any effect. Subsequent studies with mCherry reporter strains revealed that P_erm* failed to drive expression during the product synthesis phase but that use of two synthetic promoters (<em>P</em>_{<em>kasOP*</em>} and <em>P</em>_<em>41</em>) enabled strong constitutive expression during the entire process. Using <em>P</em>_{<em>kasOP*</em>}, several rounds of metabolic engineering successively streamlined expression of genes involved in the pentose phosphate pathway, the shikimic acid pathway, supply of CoA esters, and nybomycin biosynthesis and export, which more than doubled the nybomycin titer to 1.7 mg L⁻¹ in the sixth-generation strain NYB-6B. In addition, we identified the minimal set of <em>nyb</em> genes needed to synthetize the molecule using single-gene-deletion strains. Subsequently, deletion of the regulator <em>nybW</em> enabled nybomycin production to begin during the growth phase, further boosting the titer and productivity. Based on RNA sequencing along the created strain genealogy, we discovered that the <em>nyb</em> gene cluster was unfavorably downregulated in all advanced producers. This inspired removal of a part and the entire set of the four regulatory genes at the 3′-end <em>nyb</em> of the cluster. The corresponding mutants NYB-8 and NYB-9 exhibited marked further improvement in production, and the deregulated cluster was combined with all beneficial targets from primary metabolism. The best strain, <em>S. albidoflavus</em> NYB-11, accumulated up to 12 mg L⁻¹ nybomycin, fifteenfold more than the basic strain. The absence of native gene clusters in the host and use of a lean minimal medium contributed to a selective production process, providing an important next step toward further development of nybomycin.</p></div>","PeriodicalId":18483,"journal":{"name":"Metabolic engineering","volume":null,"pages":null},"PeriodicalIF":8.4,"publicationDate":"2023-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1096717623001775/pdfft?md5=86ba2bdf60efc2296a6829636c79209c&pid=1-s2.0-S1096717623001775-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138561630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Engineering Yarrowia lipolytica for sustainable ricinoleic acid production: A pathway to free fatty acid synthesis","authors":"Kwanghyun Park,&nbsp;Ji-Sook Hahn","doi":"10.1016/j.ymben.2023.12.002","DOIUrl":"10.1016/j.ymben.2023.12.002","url":null,"abstract":"<div><p>Ricinoleic acid (C18:1-OH, RA) is a valuable hydroxy fatty acid with versatile applications. The current industrial source of RA relies on the hydrolysis of castor bean oil. However, the coexistence of the toxic compound ricin and the unstable supply of this plant have led to an exploration of promising alternatives: generating RA in heterologous plants or microorganisms. In this study, we engineered the oleaginous yeast <em>Yarrowia lipolytica</em> to produce RA in the form of free fatty acids (FFA). First, we overexpressed fungal Δ12 oleate hydroxylase gene (<em>CpFAH12</em>) from <em>Claviceps purpurea</em> while deleting genes related to fatty acid degradation (<em>MEF1</em> and <em>PEX10</em>) and oleic acid desaturation (<em>FAD2</em>). Since Δ12 oleate hydroxylase converts oleic acid (C18:1) located at the <em>sn</em>-2 position of phosphatidylcholine (PC), we next focused on increasing the PC pool containing oleic acid. This objective was achieved thorough implementing metabolic engineering strategies designed to enhance the biosynthesis of PC and C18 fatty acids. To increase the PC pool, we redirected the flux towards phospholipid biosynthesis by deleting phosphatidic acid phosphatase genes (<em>PAH1</em> and <em>APP1</em>) and diacylglycerol acyltransferase gene (<em>DGA1</em>), involved in the production of diacylglycerol and triacylglycerol, respectively. Furthermore, the PC biosynthesis via the CDP-DAG pathway was enhanced through the overexpression of <em>CDS1</em>, <em>PSD1</em>, <em>CHO2</em>, and <em>OPI3</em> genes. Subsequently, to increase the oleic acid content within PC, we overexpressed the heterologous fatty acid elongase gene (<em>MaC16E</em>) involved in the conversion of C16 to C18 fatty acids. As RA production titer escalated, the produced RA was mainly found in the FFA form, leading to cell growth inhibition. The growth inhibition was mitigated by inducing RA secretion via Triton X-100 treatment, a process that simultaneously amplified RA production by redirecting flux towards RA synthesis. The final engineered strain JHYL-R146 produced 2.061 g/L of free RA in a medium treated with 5% Triton X-100, constituting 74% of the total FFAs produced. Generating free RA offers the added benefit of bypassing the hydrolysis stage required when employing castor bean oil as an RA source. This achievement represents the highest level of RA synthesis from glucose reported thus far, underscoring the potential of <em>Y. lipolytica</em> as a host for sustainable RA production.</p></div>","PeriodicalId":18483,"journal":{"name":"Metabolic engineering","volume":null,"pages":null},"PeriodicalIF":8.4,"publicationDate":"2023-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1096717623001751/pdfft?md5=b6f87d62a2e6305fdfc435ddd1a02e62&pid=1-s2.0-S1096717623001751-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138561625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Development of Corynebacterium glutamicum as a monoterpene production platform","authors":"Bridget A. Luckie ,&nbsp;Meera Kashyap ,&nbsp;Allison N. Pearson ,&nbsp;Yan Chen ,&nbsp;Yuzhong Liu ,&nbsp;Luis E. Valencia ,&nbsp;Alexander Carrillo Romero ,&nbsp;Graham A. Hudson ,&nbsp;Xavier B. Tao ,&nbsp;Bryan Wu ,&nbsp;Christopher J. Petzold ,&nbsp;Jay D. Keasling","doi":"10.1016/j.ymben.2023.11.009","DOIUrl":"10.1016/j.ymben.2023.11.009","url":null,"abstract":"<div><p>Monoterpenes are commonly known for their role in the flavors and fragrances industry and are also gaining attention for other uses like insect repellant and as potential renewable fuels for aviation. <em>Corynebacterium glutamicum,</em> a Generally Recognized as Safe microbe, has been a choice organism in industry for the annual million ton-scale bioproduction of amino acids for more than 50 years; however, efforts to produce monoterpenes in <em>C. glutamicum</em> have remained relatively limited. In this study, we report a further expansion of the <em>C. glutamicum</em> biosynthetic repertoire through the development and optimization of a mevalonate-based monoterpene platform. In the course of our plasmid design iterations, we increased flux through the mevalonate-based bypass pathway, measuring isoprenol production as a proxy for monoterpene precursor abundance and demonstrating the highest reported titers in <em>C. glutamicum</em> to date at 1504.6 mg/L. Our designs also evaluated the effects of backbone, promoter, and GPP synthase homolog origin on monoterpene product titers. Monoterpene production was further improved by disrupting competing pathways for isoprenoid precursor supply and by implementing a biphasic production system to prevent volatilization. With this platform, we achieved 321.1 mg/L of geranoids, 723.6 mg/L of 1,8-cineole, and 227.8 mg/L of linalool. Furthermore, we determined that <em>C. glutamicum</em> first oxidizes geraniol through an aldehyde intermediate before it is asymmetrically reduced to citronellol. Additionally, we demonstrate that the aldehyde reductase, AdhC, possesses additional substrate promiscuity for acyclic monoterpene aldehydes.</p></div>","PeriodicalId":18483,"journal":{"name":"Metabolic engineering","volume":null,"pages":null},"PeriodicalIF":8.4,"publicationDate":"2023-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1096717623001738/pdfft?md5=029fda2f52c17ebb474c7d79aad3dfa9&pid=1-s2.0-S1096717623001738-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138485703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efficient production of an antitumor precursor actinocin and other medicinal molecules from kynurenine pathway in Escherichia coli","authors":"Komal Sharma ,&nbsp;Mohammad Rifqi Ghiffary ,&nbsp;GaRyoung Lee ,&nbsp;Hyun Uk Kim","doi":"10.1016/j.ymben.2023.11.008","DOIUrl":"10.1016/j.ymben.2023.11.008","url":null,"abstract":"<div><p>Kynurenine pathway has a potential to convert L-tryptophan into multiple medicinal molecules. This study aims to explore the biosynthetic potential of kynurenine pathway for the efficient production of actinocin, an antitumor precursor selected as a proof-of-concept target molecule. Kynurenine pathway is first constructed in <em>Escherichia coli</em> by testing various combinations of biosynthetic genes from four different organisms. Metabolic engineering strategies are next performed to improve the production by inhibiting a competing pathway, and enhancing intracellular supply of a cofactor <em>S</em>-adenosyl-L-methionine, and ultimately to produce actinocin from glucose. Metabolome analysis further suggests additional gene overexpression targets, which finally leads to the actinocin titer of 719 mg/L. <em>E. coli</em> strain engineered to produce actinocin is further successfully utilized to produce 350 mg/L of kynurenic acid, a neuroprotectant, and 1401 mg/L of 3-hydroxyanthranilic acid, an antioxidant, also from glucose. These competitive production titers demonstrate the biosynthetic potential of kynurenine pathway as a source of multiple medicinal molecules. The approach undertaken in this study can be useful for the sustainable production of molecules derived from kynurenine pathway, which are otherwise chemically synthesized.</p></div>","PeriodicalId":18483,"journal":{"name":"Metabolic engineering","volume":null,"pages":null},"PeriodicalIF":8.4,"publicationDate":"2023-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1096717623001726/pdfft?md5=b230d3b45d678246b960bd7968581529&pid=1-s2.0-S1096717623001726-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138473728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}